Back to search results

Pain Management for Hip Surgery in Children with Cerebral Palsy

This study is looking at different ways to manage pain after hip surgery in children under 18 with cerebral palsy (CP) or similar muscle conditions. We want to see if injecting pain medicine directly into the surgical area works better than epidural anesthesia (medicine given into the spine). The injection uses a combination of medicines called ropivacaine, epinephrine, and ketorolac. The epidural uses bupivacaine, lidocaine, or ropivacaine. The main goal is to see which method leads to less need for strong pain medicines (narcotics) in the first 48 hours after surgery. This study is for children who are having hip surgery and have not used opioids before, and are not allergic to the study medications. The study is currently not actively recruiting participants.

Study design
This is an interventional study planning to enroll 90 participants. It compares two different pain management approaches.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, narcotic consumption, is measured for the first 48 hours after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06189781

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

Recruiting
PHASE4Up to 18InterventionalTreatment
University of California, Los Angeles
~90 participants
Updated 2024-06-11 on ClinicalTrials.gov
What's tested:Ropivacaine injectionBupivacaine, lidocaine, ropivacaine

At a glance

Recruiting sites
3 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Average postoperative narcotic consumption measured in morphine equivalents per kilograms of patient body weight
Measured over First 48 hours after surgery

Conditions

Cerebral Palsy
Hip Dysplasia
Pain, Postoperative

Explore related trials

Cerebral PalsyHip Dysplasia

Where it's being run

4 sites across 2 states
California3
Illinois1

Study leadership

  • Rachel M Thompson, MD · PRINCIPAL_INVESTIGATOR · University of California, Los Angeles

Who to contact

Rachel M Thompson, MD
[email protected]
213-742-1369
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

under 18 years old
diagnosis of cerebral palsy or similar neuromuscular disease
undergoing uni- or bilateral proximal femoral osteotomy

Exclusion

ongoing preoperative opioid use
history of allergic reaction to any component of the pain injection
history of adverse reaction to epidural anesthesia

What this trial measures

  • Average postoperative narcotic consumption measured in morphine equivalents per kilograms of patient body weightFirst 48 hours after surgery

    This describes one outcome measure where the amount of opiates consumed will be expressed in morphine equivalents divided by the body weight of patients measured in kilograms.